241 results
IVORY FINALE study: Low-dose interleukin-2 for the reduction of vascular inflammation in ACS - Clinical outcomes and follow-up
31 Aug 2024
Aaysha Cader interviews Rouchelle Sriranjan about the results of the IVORY and IVORY 2 trials which she presented at the ESC Congress 2024 in London.
The trials examined low-dose interleukin-2 therapy to reduce arterial inflammation in acute coronary syndrome patients. The study found a 7.7% reduction in arterial inflammation...
Author
Author
Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: the COLOCT randomized clinical trial
27 Aug 2024
The rationale for this study was to provide direct evidence of colchicine's effects on plaque stabilization, particularly by assessing changes in plaque characteristics using optical coherence tomography (OCT).
Reviewer
Reviewer
SENIOR-RITA - Older patients with non-ST segment elevation myocardial infarction randomised interventional treatment trial
02 Sep 2024
Mirvat Alasnag provides her take on the SENIOR-RITA trial, presented by Vijay Kunadian at the ESC Congress 2024 in London.
Author
Completeness of revascularisation in acute coronary syndrome patients with multivessel disease
28 Jun 2024
Explore evidence on complete revascularisation for patients with STEMI or NSTEMI and multivessel disease, and provide insights into the roles of intracoronary guidance by physiology and imaging.
Durable-polymer versus biodegradable-polymer drug-eluting stents in acute coronary syndromes: three-year outcomes of the HOST REDUCE POLYTECH RCT Trial
20 Jun 2024
This trial found that, in ACS patients undergoing PCI, DP-DES and BP-DES had similar patient-oriented outcomes at three years, but BP-DES had higher device-oriented composite outcomes, mainly due to increased TLR risk.
Reviewer
Intravascular ultrasound vs angiography-guided drug-coated balloon angioplasty: the ULTIMATE III trial
13 Jun 2024
The results of this study show that IVUS guidance is associated with less late lumen loss compared to angiography guidance in HBR patients undergoing DCB angioplasty.
Reviewer
One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes
03 Jun 2024
The optimal duration of short DAPT in ACS patients is unknown, therefore this analysis of the XIENCE Short DAPT programme compared the clinical outcomes of one versus three months DAPT in HBR patients with and without ACS.
Reviewer
Multivessel disease in ACS - which lesions to treat and when
21 May 2024
Watch the replay of this webinar with S. Biscaglia, V. Paradies and P. Smits on how to learn about new evidence for complete revascularisation in ACS and much more!
PCI of bifurcation lesions: management of complications - Part 3
17 May 2024 – From EuroPCR 2024
This session features additional selected EuroPCR 2024 clinical case submissions focusing on the management of complications during PCI of bifurcation lesions. Cases cover topics such as iatrogenic left main endarterectomy, left main dissections, and unexpected complications during various bifurcation stenting techniques. Discussions emphasize the importance of...
Cracking open the discussion on the clinical experience with intravascular lithotripsy in acute coronary syndromes
16 May 2024 – From EuroPCR 2024
Explore this session to uncover the common association between calcium and acute coronary syndrome, and how intravascular lithotripsy (IVL) offers a safe solution for calcified lesions, with comparable procedural success rates. However, note that ACS cases involving calcium may lead to higher major adverse cardiac events...
Acute coronary syndromes
16 May 2024 – From EuroPCR 2024
This session, in collaboration with various cardiology societies, focuses on the management of acute coronary syndromes (ACS). It presents three case studies, covering the management of culprit lesions in ACS, tips and tricks in difficult situations, and the management of multivessel disease. The discussions aim to...
Challenging scenarios in NSTEMI
16 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that explore complex and challenging scenarios encountered in the management of NSTEMI patients. Participants will delve into discussions on topics such as coronary artery aneurysm, restenosis of coronary ostial stents, right-sided chest pain, subsequent occlusions of the left anterior...
Innovative approaches to rare PCI complications in NSTEMI
16 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that explore complex PCI scenarios in NSTEMI patients. Participants will learn about rare complications following coronary angioplasty, strategies for identifying the correct culprit lesion, techniques for managing pericardial effusion, and other challenging situations encountered during complex PCI in NSTEMI....
Optimising the procedural techniques to treat calcified coronary lesions
16 May 2024 – From EuroPCR 2024
This session will provide insights into various techniques and strategies for treating severely calcified coronary lesions. Participants will learn about the use of IVUS guidance, rotational atherectomy, and other plaque modification tools to overcome challenging calcified lesions and achieve optimal stent deployment.
Acute coronary syndromes due to coronary dissection
16 May 2024 – From EuroPCR 2024
This session will explore various cases of acute coronary syndromes caused by coronary dissection. Participants will learn about the diagnosis, management, and treatment strategies for spontaneous coronary artery dissection, including the use of imaging and interventional techniques to address these challenging cases.
How to solve tricky coronary complications
16 May 2024 – From EuroPCR 2024
From balloon rupture during double-kissing crush stenting to a successful bailout for delayed coronary obstruction post-TAVI, and an unforeseen complication after chimney stenting in a high-risk patient, the session covers it all. Learn about the nuclear mushroom phenomenon during PCI in a calcified LAD, strategies for...
Acute coronary syndrome caused by coronary aneurysms
16 May 2024 – From EuroPCR 2024
This session will explore various cases of acute coronary syndromes caused by coronary artery aneurysms. Participants will learn about the diagnosis, management, and treatment strategies for these rare and complex cases, including the use of imaging and interventional techniques to address the underlying pathology.
Stent loss and coronary perforation: how to deal with
16 May 2024 – From EuroPCR 2024
This session explores the management of challenging complications during percutaneous coronary interventions, such as stent loss and coronary perforation. The presenters share case studies that demonstrate various techniques and strategies used to address these complications, including the use of CTO wires for distal wire perforation, managing...
Challenges in acute coronary syndrome treatment
16 May 2024 – From EuroPCR 2024
This session delves into the challenges and emerging insights in the treatment of acute coronary syndrome (ACS). It features presentations and discussions on topics such as sex-based differences in treatment and outcomes in STEMI, the use of ticagrelor de-escalation strategy in CKD patients, the outcomes of...
Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options
15 May 2024 – From EuroPCR 2024
In this session, uncover new data on Murray-law based quantitative flow ratio (muFR) assessment, providing a comprehensive understanding of PCI outcomes from a single angiographic view, explore the innovative application of artificial intelligence in identifying vulnerable plaque and assessing hemodynamic stenosis significance through the analysis of...
